Vafidemstat API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Vafidemstat API 1357362-02-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Vafidemstat. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Vafidemstat
- Synonyms:
- Cas Number:
- 1357362-02-7
- DrugBank number:
- DB16446
- Unique Ingredient Identifier:
- LZ82JLT4UP
General Description:
Vafidemstat, identified by CAS number 1357362-02-7, is a notable compound with significant therapeutic applications. Vafidemstat is under investigation in clinical trial NCT03867253 (Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease).
Mechanism of Action:
Vafidemstat functions by: Vafidemstat is a small molecule irreversible inhibitor of histone demethylase LSD1 and also a dual inhibitor of LSD1/MAO-B. This mechanism highlights the drug's role in inhibiting or promoting specific biological pathways, contributing to its therapeutic effects.
Categories:
Vafidemstat is categorized under the following therapeutic classes: Oxazoles. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
